Updated clinical recommendations for the use of tibolone in Asian women

Author： Huang K-E.   Baber R.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.13, Iss.4, 2010-08, pp. : 317-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tibolone is not aromatized in postmenopausal women

By  

Climacteric, Vol. 11, Iss. 2, 2008-01 ,pp. : 175-176

Informa Healthcare

Access to resources Recommend Favorite

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

By Dimitrakakis C.   Keramopoulos D.   Vourli G.   Gaki V.   Bredakis N.   Keramopoulos A.  

Climacteric, Vol. 8, Iss. 4, 2005-12 ,pp. : 342-351

Informa Healthcare

Access to resources Recommend Favorite

Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus® study

By Wierik EJM Velthuis-te   Hendricks PT   Boerstoel-Streefland M.  

Climacteric, Vol. 7, Iss. 2, 2004-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of tibolone effect on arterial resistance in postmenopausal women

By Grinbaum M. L.   Ferreira J. A. de S.   Fernandes C. E.   de Azevedo L. H.  

Climacteric, Vol. 6, Iss. 2, 2003-06 ,pp. : 151-158

Informa Healthcare

Access to resources Recommend Favorite

Effects of tibolone on plasma homocysteine levels in postmenopausal women

By Celik H.   Ayar A.   Tug N.   Cikim G.   Kilic N.   Parmaksiz C.  

Fertility and Sterility, Vol. 78, Iss. 2, 2002-08 ,pp. : 347-350

Elsevier

Access to resources Recommend Favorite